These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 18679541)
1. Evidence that amitriptyline may be effective in treating diarrhea-predominant irritable bowel syndrome. Lundberg GD Medscape J Med; 2008 Jun; 10(6):132. PubMed ID: 18679541 [No Abstract] [Full Text] [Related]
2. A reader responds to "Evidence that amitriptyline may be effective in treating diarrhea-predominant irritable bowel syndrome". Lakhan SE Medscape J Med; 2008 Jun; 10(6):150. PubMed ID: 18679555 [No Abstract] [Full Text] [Related]
4. Clinical trial: the effect of amitriptyline in patients with diarrhoea-predominant irritable bowel syndrome. Vahedi H; Merat S; Momtahen S; Kazzazi AS; Ghaffari N; Olfati G; Malekzadeh R Aliment Pharmacol Ther; 2008 Apr; 27(8):678-84. PubMed ID: 18248658 [TBL] [Abstract][Full Text] [Related]
5. Tianeptine vs amitriptyline for the treatment of irritable bowel syndrome with diarrhea: a multicenter, open-label, non-inferiority, randomized controlled study. Sohn W; Lee OY; Kwon JG; Park KS; Lim YJ; Kim TH; Jung SW; Kim JI Neurogastroenterol Motil; 2012 Sep; 24(9):860-e398. PubMed ID: 22679908 [TBL] [Abstract][Full Text] [Related]
6. A meta-analysis of the therapeutic effects of amitriptyline for treating irritable bowel syndrome. Chao GQ; Zhang S Intern Med; 2013; 52(4):419-24. PubMed ID: 23411695 [TBL] [Abstract][Full Text] [Related]
7. Evidence-based medicine in practice: applying intention-to-treat analysis and perprotocol analysis. Schoenfeld PS Am J Gastroenterol; 2005 Jan; 100(1):3-4. PubMed ID: 15654771 [No Abstract] [Full Text] [Related]
8. Medical Therapies for Diarrhea-Predominant Irritable Bowel Syndrome. Sayuk GS Gastroenterol Clin North Am; 2021 Sep; 50(3):611-637. PubMed ID: 34304791 [TBL] [Abstract][Full Text] [Related]
9. Double-blind placebo-controlled trial of amitriptyline for the treatment of irritable bowel syndrome in adolescents. Bahar RJ; Collins BS; Steinmetz B; Ament ME J Pediatr; 2008 May; 152(5):685-9. PubMed ID: 18410774 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of dioctahedral smectite in treating patients of diarrhea-predominant irritable bowel syndrome. Chang FY; Lu CL; Chen CY; Luo JC J Gastroenterol Hepatol; 2007 Dec; 22(12):2266-72. PubMed ID: 17559369 [TBL] [Abstract][Full Text] [Related]
11. Eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome. The SEPD perspective. Vera I; Júdez FJ Rev Esp Enferm Dig; 2017 Nov; 109(11):788-794. PubMed ID: 28747053 [TBL] [Abstract][Full Text] [Related]
12. Eluxadoline approved for irritable bowel syndrome with diarrhea. Traynor K Am J Health Syst Pharm; 2015 Jul; 72(13):1078. PubMed ID: 26092951 [No Abstract] [Full Text] [Related]
13. Efficacy and indication optimization of Chinese medicine (Tiao-Chang Ke-Min granules) for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized controlled trial. Li Q; Zhang BP; Huang SG; Ouyang WW; Xie JH; Wen ZH; Yang XB Trials; 2018 Jul; 19(1):367. PubMed ID: 29996882 [TBL] [Abstract][Full Text] [Related]
14. [Low-dose amitriptyline for irritable bowel syndrome]. Langhorst J; Nitschmann S Inn Med (Heidelb); 2024 Apr; 65(4):414-416. PubMed ID: 38483555 [No Abstract] [Full Text] [Related]
16. Eluxadoline (Viberzi) for irritable bowel syndrome with diarrhea. Med Lett Drugs Ther; 2016 Jan; 58(1485):4-5. PubMed ID: 26714241 [No Abstract] [Full Text] [Related]
17. Update on the Management of Diarrhea-Predominant Irritable Bowel Syndrome: Focus on Rifaximin and Eluxadoline. Rivkin A; Rybalov S Pharmacotherapy; 2016 Mar; 36(3):300-16. PubMed ID: 26971716 [TBL] [Abstract][Full Text] [Related]
18. Update on Eluxadoline for the Treatment of Irritable Bowel Syndrome with Diarrhea: Patient Selection and Perspectives. Liu R; Staller K Drug Des Devel Ther; 2020; 14():1391-1400. PubMed ID: 32308371 [TBL] [Abstract][Full Text] [Related]
19. Low-dose amitriptyline in irritable bowel syndrome: ready for primary care? de Wit N; Keszthelyi D Lancet; 2023 Nov; 402(10414):1727-1728. PubMed ID: 37858321 [No Abstract] [Full Text] [Related]
20. Alosetron for severe diarrhea-predominant irritable bowel syndrome: improving patient outcomes. Bleser S Curr Med Res Opin; 2011 Mar; 27(3):503-12. PubMed ID: 21208139 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]